Table 5.

Interaction between current estrogen use and total number of copies of factor XIIIA Leu34 and factor XIIIB Arg95 alleles on risk of nonfatal myocardial infarction


Estrogen use

No. of factor XIII variant alleles*

No. of cases

No. of controls

Odds ratio (95% CI)

P

Measure

Point estimate (95% CI)

P
Not current   < 2   135   376   1.00 (reference)    OR for < 2 copies  1.41 (0.96-2.07)   .07  
Current   < 2   74   218   1.40 (0.96-2.04)   .08     
Not current   ≥ 2   19   77   0.85 (0.47-1.55)   .59   OR for ≥ 2 copies  0.43 (0.14-1.30)   .13  
Current
 
≥ 2
 
6
 
50
 
0.33 (0.13-0.85)
 
.02
 

 

 

 

Estrogen use

No. of factor XIII variant alleles*

No. of cases

No. of controls

Odds ratio (95% CI)

P

Measure

Point estimate (95% CI)

P
Not current   < 2   135   376   1.00 (reference)    OR for < 2 copies  1.41 (0.96-2.07)   .07  
Current   < 2   74   218   1.40 (0.96-2.04)   .08     
Not current   ≥ 2   19   77   0.85 (0.47-1.55)   .59   OR for ≥ 2 copies  0.43 (0.14-1.30)   .13  
Current
 
≥ 2
 
6
 
50
 
0.33 (0.13-0.85)
 
.02
 

 

 

 

OR indicates odds ratio; CI, confidence interval. Odds ratios for current estrogen use compared to not current (past or never) use were adjusted for age, race, calendar year, treated hypertension status, current smoking, diabetes, systolic blood pressure, and cholesterol.

*

Total copy number of factor XIIIA Leu34 and factor XIIIB Arg95 alleles.

Odds ratio for myocardial infarction associated with current estrogen use among subjects with the indicated number of factor XIII variant alleles.

Close Modal

or Create an Account

Close Modal
Close Modal